Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Nanxin Pharmaceutical: Nanxin Pharmaceutical Report for the Third Quarter of 2024
Oct 30, 2024 12:00 ET
Nanxin Pharmaceutical Report for the Third Quarter of 2024
Nanxin Pharmaceutical 2024 Semi-Annual Report
Aug 29, 2024 12:00 ET
Summary of Nanxin Pharmaceutical\'s 2024 Semi-Annual Report
Read more
No Data